Shionogi & Co., Ltd.

Oct 11, 2019

Shionogi enters into a new license agreement and research collaboration for the treatment of mycobacterial diseases with Hsiri Therapeutics, Inc.

Jun 24, 2019

Shionogi Concludes Licensing Agreements with Eddingpharm for Lusutrombopag, a Thrombopoietin Receptor Agonist

Dec 05, 2018

Vast Therapeutics Announces Series A Funding

Jun 06, 2018

Shionogi enters into a license and research collaboration for the treatment of mycobacterial diseases with Hsiri Therapeutics, Inc.

Jan 05, 2018

PharmaIN and Shionogi Announce Collaboration and $17M Securities Purchase Agreements

Oct 05, 2017

Shionogi To Present S-033188 Phase 3 CAPSTONE-1 Study Results For Treatment Of Influenza At IDWeek 2017

Oct 04, 2017

Shionogi Presents Positive Clinical Efficacy Trial Results And In Vitro Data On Cefiderocol, At IDWeek 2017